Cme (CME) Shares Outstanding (Diluted Average) (2009 - 2026)

Cme (CME) has 18 years of Shares Outstanding (Diluted Average) data on file, last reported at $363.2 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $363.2 million, up 0.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $363.2 million (up 0.83% YoY), and the FY2025 annual result was $360.3 million, changed 0.1% from the prior year.
• Shares Outstanding (Diluted Average) rose to $363.2 million in Q1 2026 per CME's latest filing, from $360.3 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $363.2 million in Q1 2026 and troughed at $359.2 million in Q2 2022.
• A 5-year average of $359.9 million and a median of $359.8 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Diluted Average) rose 0.04% in 2023, then grew 0.83% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $359.2 million in 2022, then grew by 0.09% to $359.5 million in 2023, then gained by 0.12% to $359.9 million in 2024, then increased by 0.1% to $360.3 million in 2025, then advanced by 0.8% to $363.2 million in 2026.
• Business Quant data shows CME's Shares Outstanding (Diluted Average) at $363.2 million in Q1 2026, $360.3 million in Q4 2025, and $360.3 million in Q3 2025.